Partnering and licensing2017-11-15T02:20:35+00:00

Partnering and Licensing

Ology’s VERO CELL PLATFORM (DMF 10336, Master and Working Cell banks) is optimized for production of vaccines.

Fully characterized, successful track record:

  • Vero cell vaccines are licensed in the EU as well as in the US, Australia, New Zealand and Brazil

  • Adapted to serum-free media

  • Suitable for production of all types of viral vaccines:

    • inactivated whole virus
    • live-attenuated
    • split/subunit

Barrett et al, Expert Rev. Vaccines 8(5), 607-618 (2009).
Barrett et al, Expert Rev. Vaccines 16(9), 883-894 (2017).

See the references

Vero Cells